Literature DB >> 2547506

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma.

J E Haas1, K A Muczynski, M Krailo, A Ablin, V Land, T J Vietti, G D Hammond.   

Abstract

To determine the relationship between outcome and histologic type, the authors examined data from 168 cases of hepatoblastoma (HB) and 28 cases of hepatocarcinoma (HC) accrued from children over a 14-year period. After adjustment for stage of disease, there was no significant difference in median survival between HB and HC. Mitotic activity was associated with poor prognosis. Necrosis or vascular invasion did not influence prognosis. In 55 cases of completely resected HB, pure fetal histologic type (PFH) was associated with improved survival when compared with all other histologic patterns of HB (92% versus 57% 24 months' survival; P = 0.02). A prognostic effect of PFH was not demonstrable in incompletely resected HB, but the absence of mitoses and the presence of differentiated mesenchymal elements improved survival. The fibrolamellar pattern of HC demonstrated survival similar to that of the typical pattern of HC. The authors conclude that features consistent with differentiation in HB convey improved prognosis for survival. These observations may be important in designing future therapy for children with hepatic tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2547506     DOI: 10.1002/1097-0142(19890901)64:5<1082::aid-cncr2820640520>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Cytomorphology of some uncommon tumors of childhood and adolescence.

Authors:  U R Singh; K Gupta; V K Arora; S Gupta; A Bhatia
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Emergency hepatic resection a life saving procedure in ruptured hepatoblastoma: case report.

Authors:  Gururaj Deshpande; Mahesh D Patel
Journal:  Indian J Surg Oncol       Date:  2013-02-13

3.  Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma.

Authors:  Minu Bajpai; K Pal; S Agarwala; Tulika Seth; Arun K Gupta
Journal:  Pediatr Surg Int       Date:  2005-04-19       Impact factor: 1.827

4.  Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.

Authors:  Marcio H Malogolowkin; Howard M Katzenstein; Rebecka L Meyers; Mark D Krailo; Jon M Rowland; Joel Haas; Milton J Finegold
Journal:  J Clin Oncol       Date:  2011-07-18       Impact factor: 44.544

5.  Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Basile Njei; Venkata Rajesh Konjeti; Ivo Ditah
Journal:  Gastrointest Cancer Res       Date:  2014-03

6.  The clinical features and prognosis of hepatoblastoma: follow-up studies done on pediatric tumors enrolled in the Japanese Pediatric Tumor Registry between 1971 and 1980. Part I. Committee of Malignant Tumors, Japanese Society of Pediatric Surgeons.

Authors:  Y Hata
Journal:  Jpn J Surg       Date:  1990-09

7.  ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells.

Authors:  Duo-te Cai; Hua Jin; Qi-Xing Xiong; Wei-Guang Liu; Zhi-gang Gao; Gui-xiong Gu; Yu-hui Qiu
Journal:  Mol Cell Biochem       Date:  2013-04-12       Impact factor: 3.396

Review 8.  Liver cancer stem cells.

Authors:  Stewart Sell; Hyam L Leffert
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

Review 9.  Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.

Authors:  Stewart Sell
Journal:  Tumour Biol       Date:  2008-07-09

10.  Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

Authors:  Celina S Ang; R Katie Kelley; Michael A Choti; David P Cosgrove; Joanne F Chou; David Klimstra; Michael S Torbenson; Linda Ferrell; Timothy M Pawlik; Yuman Fong; Eileen M O'Reilly; Jennifer Ma; Joseph McGuire; Gandhi P Vallarapu; Ann Griffin; Francesco Stipa; Marinela Capanu; Ronald P Dematteo; Alan P Venook; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.